Eco R1 Capital, LLC Kinnate Biopharma Inc. Transaction History

Eco R1 Capital, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	BUY	$17.81 - $24.87 $2.67 Million - $3.73 Million	150,000 Added 600.0%	175,000 $4.03 Million
Q4 2020 Feb 16, 2021	BUY	$36.35 - $45.25 $908,750 - $1.13 Million	25,000 New	25,000 $995,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.